Cullinan Therapeutics (CGEM) Institutional Ownership $7.87 -0.03 (-0.38%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$7.86 -0.01 (-0.13%) As of 05/21/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cullinan Therapeutics (NASDAQ:CGEM)CurrentInstitutional OwnershipPercentage86.31%Number ofInstitutional Buyers(last 12 months)100TotalInstitutional Inflows(last 12 months)$238.25MNumber ofInstitutional Sellers(last 12 months)36TotalInstitutional Outflows(last 12 months)$53.08M Get CGEM Insider Trade Alerts Want to know when executives and insiders are buying or selling Cullinan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGEM Institutional Buying and Selling by Quarter Cullinan Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2025Acadian Asset Management LLC81,721$618K0.0%N/A0.138% 5/19/2025 Jane Street Group LLC34,396$260K0.0%-145.9%0.058% 5/16/2025 Woodline Partners LP81,741$619K0.0%-51.1%0.139% 5/16/2025 Goldman Sachs Group Inc.648,957$4.91M0.0%-5.3%1.100% 5/16/2025 Dynamic Technology Lab Private Ltd21,581$163K0.0%N/A0.037% 5/16/2025 Millennium Management LLC783,177$5.93M0.0%-6.1%1.327% 5/15/2025 Braidwell LP980,773$7.42M0.3%-16.6%1.662% 5/15/2025 Siren L.L.C.1,193,410$9.03M0.5%-1.5%2.022% 5/15/2025 Tema Etfs LLC39,164$296K0.1%+37.7%0.066% 5/15/2025 Trexquant Investment LP68,467$518K0.0%N/A0.116% Get the Latest News and Ratings for CGEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/14/2025 Rafferty Asset Management LLC54,942$416K0.0%-38.7%0.093% 5/14/2025 Walleye Capital LLC22,000$167K0.0%-85.9%0.037% 5/14/2025 AlphaQuest LLC25,090$190K0.0%N/A0.043% 5/14/2025 Martingale Asset Management L P22,132$168K0.0%-42.6%0.038% 5/14/2025 EntryPoint Capital LLC24,190$183K0.1%+65.0%0.041% 5/14/2025 Voss Capital LP175,000$1.33M0.1%+43.0%0.297% 5/14/2025 Wellington Management Group LLP161,057$1.22M0.0%+21.1%0.273% 5/13/2025 Brooklyn Investment Group4,503$34K0.0%N/A0.008% 5/13/2025 Algert Global LLC221,430$1.68M0.0%+411.5%0.375% 5/13/2025 American Century Companies Inc.112,670$853K0.0%+11.9%0.191% 5/13/2025 Russell Investments Group Ltd.29,363$222K0.0%N/A0.050% 5/12/2025 Nuveen LLC188,030$1.42M0.0%N/A0.319% 5/12/2025 Invesco Ltd.49,243$373K0.0%-17.3%0.083% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.77,621$588K0.0%+282.9%0.132% 5/9/2025 Deutsche Bank AG575,531$4.36M0.0%-0.8%0.975% 5/9/2025 Charles Schwab Investment Management Inc.424,262$3.21M0.0%-1.6%0.719% 5/9/2025 Vanguard Group Inc.3,039,731$23.01M0.0%+3.5%5.151% 5/7/2025 Corton Capital Inc.16,842$127K0.4%+41.0%0.029% 4/22/2025 Palumbo Wealth Management LLC16,268$123K0.0%N/A0.028% 4/17/2025 Exchange Traded Concepts LLC14,107$107K0.0%+42.6%0.024% 4/15/2025 Assenagon Asset Management S.A.10,062$76K0.0%-92.4%0.017% 4/8/2025 Rhumbline Advisers71,338$540K0.0%+4.6%0.122% 4/7/2025 GAMMA Investing LLC6,995$53K0.0%+1,214.8%0.012% 3/24/2025 Wellington Management Group LLP132,976$1.62M0.0%+25.4%0.227% 3/18/2025 California State Teachers Retirement System31,251$381K0.0%-14.3%0.053% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC91,792$1.12M0.0%+29.4%0.158% 2/17/2025 Woodline Partners LP167,315$2.04M0.0%N/A0.287% 2/17/2025 Squarepoint Ops LLC19,101$233K0.0%-37.9%0.033% 2/17/2025 Two Sigma Advisers LP21,900$267K0.0%+22.3%0.038% 2/17/2025 Two Sigma Investments LP42,205$514K0.0%+83.9%0.072% A new financial chapter (Ad)Porter Stansberry says what happened last week could become the defining legacy of his financial publishing career. In a special event watched by thousands, he unveiled what he calls “the boldest undertaking” he’s ever attempted — a real-money initiative that will document every trade, decision, win, and loss in pursuit of a million-dollar mission. And the results are already surprising. One early beta tester tripled her investment income in just three trades. If you missed the event, he’s republishing the message he sent to attendees right after it ended.2/17/2025 Tema Etfs LLC28,433$346K0.1%N/A0.049% 2/17/2025 Sphera Funds Management LTD.205,000$2.50M0.5%+10.3%0.352% 2/17/2025 Rafferty Asset Management LLC89,658$1.09M0.0%-21.8%0.154% 2/17/2025 ProShare Advisors LLC17,326$211K0.0%+31.2%0.030% 2/17/2025 Patient Square Capital LP878,897$10.71M4.0%+6.6%1.509% 2/17/2025Nuveen Asset Management LLC227,033$2.77M0.0%-2.8%0.390% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC56,095$683K0.1%+22.0%0.096% 2/17/2025 Orbimed Advisors LLC1,942,555$23.66M0.5%+81.5%3.336% 2/17/2025 Millennium Management LLC833,962$10.16M0.0%+5.8%1.432% 2/17/2025 D. E. Shaw & Co. Inc.48,932$596K0.0%-17.4%0.084% 2/17/2025 Deutsche Bank AG580,136$7.07M0.0%+3.4%0.996% 2/17/2025 Deerfield Management Company L.P. Series C3,379,399$41.16M0.8%+3.0%5.804% 2/17/2025 Corton Capital Inc.11,944$145K0.1%N/A0.021% 2/17/2025 Cubist Systematic Strategies LLC130,647$1.59M0.0%N/A0.224% 2/17/2025 Brevan Howard Capital Management LP14,735$179K0.0%N/A0.025% 2/17/2025 Bank of America Corp DE155,270$1.89M0.0%-62.1%0.267% 2/17/2025 BNP Paribas Financial Markets115,000$1.40M0.0%N/A0.197% 2/17/2025 Ameriprise Financial Inc.504,264$6.14M0.0%+20.8%0.866% 2/17/2025 Algert Global LLC43,292$527K0.0%+8.5%0.074% 2/14/2025 Boxer Capital Management LLC907,895$11.06M0.9%N/A1.559% 2/14/2025 Foresite Capital Management VI LLC634,558$7.73M3.4%N/A1.090% 2/14/2025 Northern Trust Corp500,908$6.10M0.0%+6.4%0.860% 2/14/2025 Lynx1 Capital Management LP1,257,795$15.32M5.7%+206.2%2.160% 2/14/2025 Aquatic Capital Management LLC6,357$77K0.0%N/A0.011% 2/14/2025 Virtus ETF Advisers LLC5,828$71K0.0%+37.8%0.010% 2/14/2025 Nebula Research & Development LLC43,702$532K0.1%+26.5%0.075% 2/14/2025 Blue Owl Capital Holdings LP2,370,972$28.88M6.8%+17.9%4.072% 2/14/2025 Adage Capital Partners GP L.L.C.1,030,438$12.55M0.0%-24.0%1.770% 2/14/2025 Price T Rowe Associates Inc. MD29,493$360K0.0%+15.3%0.051% 2/14/2025 Rock Springs Capital Management LP742,114$9.04M0.3%+0.7%1.274% 2/14/2025 Voss Capital LP122,361$1.49M0.1%N/A0.210% 2/14/2025 Tower Research Capital LLC TRC8,800$107K0.0%+411.3%0.015% 2/14/2025 MetLife Investment Management LLC32,058$390K0.0%+7.4%0.055% 2/14/2025 Dimensional Fund Advisors LP1,318,372$16.06M0.0%+28.9%2.264% 2/13/2025 Marshall Wace LLP651,693$7.94M0.0%-38.2%1.119% 2/13/2025 Jump Financial LLC66,135$806K0.0%+130.7%0.114% 2/13/2025 Walleye Capital LLC156,497$1.91M0.0%-52.3%0.269% 2/13/2025 XTX Topco Ltd43,399$529K0.0%N/A0.075% 2/13/2025 Mariner LLC34,901$425K0.0%+125.3%0.060% 2/13/2025 Barclays PLC245,231$2.99M0.0%-1.4%0.421% 2/13/2025 Optimize Financial Inc11,755$143K0.1%N/A0.020% 2/13/2025 Kennedy Capital Management LLC111,049$1.35M0.0%N/A0.191% 2/13/2025 CenterBook Partners LP43,987$536K0.0%-85.3%0.076% 2/13/2025 Martingale Asset Management L P38,545$469K0.0%+17.4%0.066% 2/13/2025 Renaissance Technologies LLC190,508$2.32M0.0%-32.4%0.327% 2/13/2025 Legal & General Group Plc42,808$521K0.0%-7.9%0.074% 2/13/2025 Invesco Ltd.59,553$725K0.0%+2.4%0.102% 2/13/2025 Federated Hermes Inc.3,802$46K0.0%+67.0%0.007% 2/13/2025 Springhill Fund Asset Management HK Co Ltd276,400$3.37M5.5%N/A0.475% 2/13/2025 Wells Fargo & Company MN24,864$303K0.0%+47.9%0.043% Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down.2/12/2025 ExodusPoint Capital Management LP23,500$286K0.0%N/A0.040% 2/12/2025 Geode Capital Management LLC1,214,641$14.80M0.0%+0.5%2.086% 2/12/2025 Franklin Resources Inc.2,199,709$26.79M0.0%+0.4%3.778% 2/12/2025 Alliancebernstein L.P.2,011,525$24.50M0.0%+8.5%3.454% 2/12/2025 Wellington Management Group LLP132,976$1.62M0.0%+25.4%0.228% 2/12/2025 NEOS Investment Management LLC28,433$346K0.0%+10.9%0.049% 2/12/2025 BIT Capital GmbH94,344$1.15M0.1%N/A0.162% 2/12/2025 JPMorgan Chase & Co.198,214$2.41M0.0%+580.9%0.340% 2/11/2025 EntryPoint Capital LLC14,657$179K0.1%N/A0.025% 2/11/2025 Corebridge Financial Inc.25,719$313K0.0%-7.0%0.044% (Data available from 1/1/2016 forward) CGEM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGEM shares? During the previous two years, 130 institutional investors and hedge funds held shares of Cullinan Therapeutics. The most heavily invested institutionals were Deerfield Management Company L.P. Series C ($41.16M), State Street Corp ($39.13M), CHI Advisors LLC ($36.74M), Blue Owl Capital Holdings LP ($28.88M), RTW Investments LP ($28.56M), Franklin Resources Inc. ($26.79M), and Holocene Advisors LP ($25.67M).Learn more on CGEM's institutional investors. What percentage of Cullinan Therapeutics stock is owned by institutional investors? 86.31% of Cullinan Therapeutics stock is owned by institutional investors. Learn more on CGEM's institutional investor holdings. Which institutional investors have been buying Cullinan Therapeutics stock? Of the 115 institutional investors that purchased Cullinan Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($2.91M), Deerfield Management Company L.P. Series C ($2.24M), Franklin Resources Inc. ($1.94M), Lynx1 Capital Management LP ($1.22M), Marshall Wace LLP ($1.14M), Boxer Capital Management LLC ($907.90K), and Patient Square Capital LP ($878.90K). How much institutional buying is happening at Cullinan Therapeutics? Institutional investors have bought a total of 21,566,982 shares in the last 24 months. This purchase volume represents approximately $294.04M in transactions. Which Cullinan Therapeutics major shareholders have been selling company stock? Of the 45 institutional investors that sold Cullinan Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: American International Group Inc. ($1.23M), Blue Owl Capital Holdings LP ($875.67K), Braidwell LP ($863.40K), Marshall Wace LLP ($402.07K), Adage Capital Partners GP L.L.C. ($325.44K), Walleye Capital LLC ($306.42K), and CenterBook Partners LP ($254.68K). How much institutional selling is happening at Cullinan Therapeutics? Institutional investors have sold a total of 6,168,671 shares in the last 24 months. This volume of shares sold represents approximately $84.77M in transactions. Related Companies RXRX Major Shareholders TARS Major Shareholders BEAM Major Shareholders APGE Major Shareholders SDGR Major Shareholders CNTA Major Shareholders BHC Major Shareholders ARQT Major Shareholders AGIO Major Shareholders GLPG Major Shareholders This page (NASDAQ:CGEM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CGEM Stock Free CGEM Stock Alerts